Time & Location:
May 5th 2007 (Saturday) 9:00-20:00
Hospira, Build H3
375 N Field Drive, Lake Forest IL
Eevent Agenda:
9:00-9:30 Registration/ Poster Mounting
9:30-9:45 Welcome
Dr. Bing Sun, President of GLCACS
9:45-9:50 Dr. Norman Li, GLCACS Board Chair
9:50-10:35 Driving R&D Results through Simplification
Dr. Jim Mitchell, VP Pharma R&D, Hospira
10:35-11:20 Speech
Mr. Thomas Chen, President, Abbott Nutrition International, Abbott
11:20-11:30 Break
11:30-12:30 Student Poster Presentations
12:30-14:30 Lunch Break
Student Poster Exhibition
Job Fair (Hospira, Abbott Laboratories, UOP and others)
Career Counseling
14:30-15:15 Biotechnology R&D in China
Dr. Jun Yu, Prof. and Associate Director, Chinese Academy of Sciences
15:15-16:00 Career Development
Mr. David Lum, Director, Asia/Pacific Product & Support, Motorola
16:00-16:15 Break
16:15-17:15 Student Poster Award and Closing Remarks
18:00-19:15 Conference Dinner
19:15-20:00 Energy Saving for Minimizing Impacts of Climate Change
Dr. Frank Zhu, Senior Associate, UOP LLC
Guest Speakers:
Driving R&D Results through Simplification - Dr. Jim Mitchell
Dr. Jim Mitchell
VP Pharma R&D, Hospira
Abstract
The presentation will focus on the spin off of the Hospital Products business (Hospira, Inc.) from Abbott Laboratories in 2004. The importance of creating a corporate Vision, Values, Strategy and 6 key principles for execution will be discussed together with the criticality of alignment between business strategy and R&D. By following this approach and implementing changes to increase cross functional collaboration, simplicity, flexibility and project governance, Hospira has been able to realize a 35%
improvement in R&D productivity without compromising product quality. The implications of these results will be discussed together with some of the initiatives Hospira is taking to drive growth in Asia and become more globally focused.
Biography
Jim Mitchell received his Ph.D. in Biochemistry from Iowa State University in 1979. During his 28-year industrial career, he has held various R&D and Operations positions in 6 different companies, including his current position as Vice President Pharmaceutical R&D at Hospira,Inc. Jim holds several patents in the areas of drug delivery and protein chemistry and has been directly involved with the successful
development and launch of over 50 proprietary and generic products. He has and continues to serve on several advisory boards and has worked at the state level to foster the funding of innovative research across a broad range of technology-based products. His multi-company R&D and management experience, ranging from drug discovery through commercialization, provides a unique prospective related to the balance between innovation, resource utilization and R&D cycle times in achieving
sustained earnings growth.
Speech by Mr. Thomas F. Chen
Biothnology R&D in China: A Personal Perspective - Dr. Jun Yu
From Geek to Chic: Practical tips, hints and suggestions to help you break through the glass ceiling - Mr. David Lum
Energy Saving for Minimizing Impact of Climate Change - Dr. Frank Zhu
Comments